Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent advances in basic science have led to a better understanding of the molecular events important in the pathogenesis of breast cancer. Very little of this new knowledge, however, has had a significant impact on improving the diagnosis and therapy of breast cancer. We review many of the molecular events important in the pathogenesis of breast cancer, including inherited abnormalities in BRCA-1 and BRCA-2,
p53
,
ATM
, and PTEN and sporadic alterations in growth factors and their receptors, signal transduction, cell cycle control, DNA repair, cell death, angiogenesis, and invasion and metastasis. We suggest ways to speed up clinical applications of the new molecular knowledge base through the use of preclinical disease models, development of high throughput sample analysis and infrastructure programs to facilitate translational research, implementation of practice guidelines, and development of regional oncology networks. Only through the implementation of such a deliberate, multifaceted strategy will the gap between the research laboratory and the clinic be closed.
...
PMID:The molecular biology of breast cancer: accelerating clinical applications. 997 46
Insulin-like growth factor (IGF)-1 inhibits apoptosis, but its mechanism is unknown. Myocyte stretching activates
p53
and
p53
-dependent genes, leading to the formation of angiotensin II (Ang II) and apoptosis. Therefore, this in vitro system was used to determine whether IGF-1 interfered with
p53
function and the local renin-angiotensin system (RAS), decreasing stretch-induced cell death. A single dose of 200 ng/ml IGF-1 at the time of stretching decreased myocyte apoptosis 43% and 61% at 6 and 20 hours. Ang II concentration was reduced 52% at 20 hours. Additionally,
p53
DNA binding to angiotensinogen (Aogen),
AT1
receptor, and Bax was markedly down-regulated by IGF-1 via the induction of Mdm2 and the formation of Mdm2-
p53
complexes. Concurrently, the quantity of
p53
, Aogen, renin,
AT1
receptor, and Bax was reduced in stretched myocytes exposed to IGF-1. Conversely, Bcl-2 and the Bcl-2-to-Bax protein ratio increased. The effects of IGF-1 on cell death, Ang II synthesis, and Bax protein were the consequence of Mdm2-induced down-regulation of
p53
function. In conclusion, the anti-apoptotic impact of IGF-1 on stretched myocytes was mediated by its capacity to depress
p53
transcriptional activity, which limited Ang II formation and attenuated the susceptibility of myocytes to trigger their endogenous cell death pathway.
...
PMID:Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. 1002 14
Telomeres play an important role in maintaining chromosomal stability and are often shortened in transformed cells.
p53
is the most commonly mutated gene in cancers and its status is thought to reflect the level of genomic stability. We measured telomeric length by Southern blot analysis in cells from cancer-prone syndromes and in selected cancer cells with altered
p53
status. Mean telomeric lengths in the cancer-prone syndromes Li-Fraumeni syndrome, Fanconi's anemia, and
ataxia telangiectasia
, were shorter in the affected individuals than in their unaffected parents. We also found that altered
p53
expression in selected cancer cell model systems may be associated with shortened telomeric length, but did not appear to be associated with significant alterations in telomerase activity.
...
PMID:Telomeric length in individuals and cell lines with altered p53 status. 1003 Jun 19
While it has long been recognized that a proportion of breast cancer cases are the result of an inherited familial predisposition, precise knowledge of the underlying genetic processes has been lacking. Recent advances in molecular biology, however, have shown that hereditary breast cancer may eventuate as a result of mutations on several specific gene loci including BRCA1, BRCA2,
ATM
gene, PTEN and
p53
. Several other less frequently occurring predisposition genes such as the androgen receptor gene (AR), the HNPCC genes and the oestrogen receptor gene may also be involved, but to a lesser extent. Overall, approximately 5-10% of all breast cancers are thought to involve one of these inherited predisposition genes, with BRCA1 and BRCA2 being responsible for as much as 90% of this group. Because of the complex nature of genetic testing, mutation analysis is not presently routinely available outside genetic counselling clinics. In this review the current knowledge and role of each predisposition gene is outlined and the management implications of genetic testing for members of breast cancer families for both affected and non-affected members are discussed. The need to provide comprehensive counselling for women with an inherited predisposition to breast cancer has seen the evolution of the familial cancer clinic, involving a multidisciplinary specialist team approach. Familial cancer clinics will provide individuals with information about their risk of developing breast cancer and offer advice regarding further management strategies. It is important that surgeons, who have traditionally played a key role in breast cancer treatment, remain cognizant of these advances in genetic molecular biology, and in so doing continue to remain key participants in the conduct of breast cancer management.
...
PMID:The genetic basis of breast cancer and its clinical implications. 1003 Aug 9
Although broken chromosomes can induce apoptosis, natural chromosome ends (telomeres) do not trigger this response. It is shown that this suppression of apoptosis involves the telomeric-repeat binding factor 2 (TRF2). Inhibition of TRF2 resulted in apoptosis in a subset of mammalian cell types. The response was mediated by
p53
and the
ATM
(ataxia telangiectasia mutated) kinase, consistent with activation of a DNA damage checkpoint. Apoptosis was not due to rupture of dicentric chromosomes formed by end-to-end fusion, indicating that telomeres lacking TRF2 directly signal apoptosis, possibly because they resemble damaged DNA. Thus, in some cells, telomere shortening may signal cell death rather than senescence.
...
PMID:p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. 1003 1
Microinjection of the restriction endonuclease HaeIII, which causes DNA double-strand breaks with blunt ends, induces nuclear accumulation of
p53 protein
in normal and xeroderma pigmentosum (XP) primary fibroblasts. In contrast, this induction of
p53
accumulation is not observed in
ataxia telangiectasia
(AT) fibroblasts. HaeIII-induced
p53 protein
in normal fibroblasts is phosphorylated at serine 15, as determined by immunostaining with an antibody specific for phosphorylated serine 15 of
p53
. This phosphorylation correlates well with
p53
accumulation. Treatment with lactacystin (an inhibitor of the proteasome) or heat shock leads to similar levels of
p53
accumulation in normal and AT fibroblasts, but the
p53 protein
lacks a phosphorylated serine 15. Following microinjection of HaeIII into lactacystin-treated normal fibroblasts, lactacystin-induced
p53 protein
is phosphorylated at serine 15 and stabilized even in the presence of cycloheximide. However, neither stabilization nor phosphorylation at serine 15 is observed in AT fibroblasts under the same conditions. These results indicate the significance of serine 15 phosphorylation for
p53
stabilization after DNA double-strand breaks and an absolute requirement for
ATM
in this phosphorylation process.
...
PMID:Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. 1008 48
Both
p53
and
ATM
are checkpoint regulators with roles in genetic stabilization and cancer susceptibility.
ATM
appears to function in the same DNA damage checkpoint pathway as
p53
. However,
ATM
's role in
p53
-dependent apoptosis and tumor suppression in response to cell cycle dysregulation is unknown. In this study, we tested the role of murine
ataxia telangiectasia
protein (Atm) in a transgenic mouse brain tumor model in which
p53
-mediated apoptosis results in tumor suppression. These
p53
-mediated activities are induced by tissue-specific inactivation of pRb family proteins by a truncated simian virus 40 large T antigen in brain epithelium. We show that
p53
-dependent apoptosis, transactivation, and tumor suppression are unaffected by Atm deficiency, suggesting that signaling in the DNA damage pathway is distinct from that in the oncogene-induced pathway. In addition, we show that Atm deficiency has no overall effect on tumor growth and progression in this model.
...
PMID:Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction. 1008 76
The simian virus 40 large tumor antigen (SV40 Tag) has been ascribed many functions critical to viral propagation, including binding to the mammalian
tumor suppressor p53
. Recent studies have demonstrated that SV40-transformed murine cells have functional
p53
. The status of
p53
in SV40-immortalized human cells, however, has not been characterized. We have found that in response to ionizing radiation,
p53
-dependent p21 transactivation activity is present, albeit reduced, in SV40-immortalized cells and that this activity can be further reduced with either dominant negative
p53
expression or higher SV40 Tag expression. Furthermore, overexpression of
p53
in SV40-immortalized
ataxia-telangiectasia
(
A-T
) cells restores
p53
-dependent p21 induction to typical
A-T
levels. All SV40-immortalized cell lines exhibited an absence of G1 arrest. Moreover, all SV40-immortalized cell lines exhibited increased apoptosis relative to primary cells in response to ionizing radiation, suggesting that SV40 immortalization results in a unique phenotype with regard to DNA damage responses.
...
PMID:The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses. 1009 28
Cells which lack DNA-activated protein kinase (DNA-PK) are very susceptible to ionizing radiation and display an inability to repair double strand DNA breaks. DNA-PK is a member of a protein kinase family that includes ATR and
ATM
which have strong homology in their carboxy-terminal kinase domain with PL-3 kinase.
ATM
has been proposed to act upstream of
p53
in cellular response to ionizing radiation. DNA-PK may similarly interact with
p53
in cellular growth control and in mediation of the response to ionizing radiation.
...
PMID:Cellular response to DNA damage. Link between p53 and DNA-PK. 1019 61
Constitutive overexpression of insulin-like growth factor-1 (IGF-1) in myocytes protects them from apoptosis and interferes with myocyte hypertrophy in the normal and pathological heart. Conversely, angiotensin II (Ang II) triggers cell death and promotes myocyte hypertrophy. Moreover, activation of
p53
upregulates the cellular renin-angiotensin system (RAS). Therefore, IGF-1 overexpression in FVB.Igf+/- mice may downregulate the local RAS through the attenuation of
p53
and
p53
-inducible genes. On this basis,
p53
DNA binding activity to angiotensinogen (Aogen), bax, and the
AT1
receptor was determined in left ventricular myocytes from FVB.Igf-/- and FVB.Igf+/- mice. The quantity of Bax, Bcl-2, Aogen, and
AT1
receptor in these cells was evaluated. The presence of Mdm2-
p53
complexes was also established. Finally, Ang II levels in myocytes were measured. Upregulation of IGF-1 in myocytes was associated with a protein-to-protein interaction between Mdm2 and
p53
, which attenuated
p53
transcriptional activity for bax, Aogen, and
AT1
receptor. Similarly, the amount of Bax, Aogen, and
AT1
receptor proteins in these cells decreased. In contrast, the expression of Bcl-2 remained constant. The downregulation of Aogen in myocytes from FVB.Igf+/- mice was characterized by a reduction in Ang II. In conclusion, IGF-1 negatively influences the myocyte RAS through the upregulation of Mdm2 and its binding to
p53
. This may represent the molecular mechanism responsible for the effects of IGF-1 on cell viability and myocyte hypertrophy in the nonpathological and pathological heart in vivo.
...
PMID:Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. 1020 43
<< Previous
1
2
3
4
5
6
7
8
9
10